|
Apr 6
|
Jim Cramer is Bearish On These 10 Stocks in April
|
|
Apr 6
|
Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock
|
|
Apr 6
|
Is it Too Late to Buy Viking Therapeutics Stock?
|
|
Apr 4
|
How to Create a Stock Portfolio that Pays $100 a Month
|
|
Apr 4
|
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
|
|
Apr 4
|
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.
|
|
Apr 4
|
LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?
|
|
Apr 3
|
Why Eli Lilly Stock Topped the Market Today
|
|
Apr 3
|
Verve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls
|
|
Apr 3
|
Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says
|
|
Apr 3
|
UPDATE 2-Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says
|
|
Apr 3
|
Dow Jones Futures: Market Rally Holds Support, Meta Near Buy Point; Tesla Skid Continues
|
|
Apr 2
|
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note
|
|
Apr 2
|
Stocks Bend As Yields Rise; Meta Platforms, Uber, Eli Lilly In Focus
|
|
Apr 2
|
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
|
|
Apr 2
|
UPDATE 1-Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
|
|
Apr 2
|
FDA website shows limited availability of some doses of Lilly's Mounjaro through April
|
|
Feb 14
|
UPDATE 1-Britain sees launch of Lilly's weight-loss drug Mounjaro
|
|
Feb 14
|
Britain sees launch of Lilly's weight-loss drug Mounjaro
|
|
Feb 14
|
Obesity-Drug Developer Altimmune Sinks on Short-Seller Report
|